These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7732854)

  • 1. Prostanoid and leukotriene receptors: a progress report from the IUPHAR working parties on classification and nomenclature.
    Coleman RA; Eglen RM; Jones RL; Narumiya S; Shimizu T; Smith WL; Dahlén SE; Drazen JM; Gardiner PJ; Jackson WT
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():283-5. PubMed ID: 7732854
    [No Abstract]   [Full Text] [Related]  

  • 2. International Union of Basic and Clinical Pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress.
    Woodward DF; Jones RL; Narumiya S
    Pharmacol Rev; 2011 Sep; 63(3):471-538. PubMed ID: 21752876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors.
    Brink C; Dahlén SE; Drazen J; Evans JF; Hay DW; Nicosia S; Serhan CN; Shimizu T; Yokomizo T
    Pharmacol Rev; 2003 Mar; 55(1):195-227. PubMed ID: 12615958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes.
    Coleman RA; Smith WL; Narumiya S
    Pharmacol Rev; 1994 Jun; 46(2):205-29. PubMed ID: 7938166
    [No Abstract]   [Full Text] [Related]  

  • 5. International Union of Pharmacology. XLVI. G protein-coupled receptor list.
    Foord SM; Bonner TI; Neubig RR; Rosser EM; Pin JP; Davenport AP; Spedding M; Harmar AJ
    Pharmacol Rev; 2005 Jun; 57(2):279-88. PubMed ID: 15914470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding to cysteinyl-leukotriene receptors.
    Nicosia S; Capra V; Ravasi S; Rovati GE
    Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 2):S46-50. PubMed ID: 10673226
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies of receptors and modulatory mechanisms in functional responses to cysteinyl-leukotrienes in smooth muscle.
    Bäck M
    Acta Physiol Scand Suppl; 2002 Feb; 648():1-55. PubMed ID: 11913222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification of prostanoid receptors.
    Gardiner PJ
    Adv Prostaglandin Thromboxane Leukot Res; 1990; 20():110-8. PubMed ID: 2144686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the characterization of prostanoid receptors.
    Kennedy I; Coleman RA; Humphrey PP; Lumley P
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():327-32. PubMed ID: 6303071
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostanoid receptor subtypes: new targets for OAB drugs?
    Andersson KE
    J Urol; 2009 Nov; 182(5):2099-100. PubMed ID: 19758658
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacologic receptors for the leukotrienes.
    Fleisch JH; Rinkema LE; Marshall WS
    Biochem Pharmacol; 1984 Dec; 33(24):3919-22. PubMed ID: 6095865
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostaglandins and leukotrienes: advances in eicosanoid biology.
    Funk CD
    Science; 2001 Nov; 294(5548):1871-5. PubMed ID: 11729303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A report on the essential changes envisaged for the new edition of bacterial nomenclature rules].
    Kandler O
    Zentralbl Bakteriol Orig A; 1974; 227(1-4):475-6. PubMed ID: 4154630
    [No Abstract]   [Full Text] [Related]  

  • 14. Intraocular pressure effects of selective prostanoid receptor agonists involve different receptor subtypes according to radioligand binding studies.
    Woodward DF; Lawrence RA; Fairbairn CE; Shan T; Williams LS
    J Lipid Mediat; 1993; 6(1-3):545-53. PubMed ID: 8358015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and experimental studies of leukotrienes as mediators of airway obstruction in humans.
    Dahlén SE; Dahlén B; Kumlin M; Björck T; Ihre E; Zetterström O
    Adv Prostaglandin Thromboxane Leukot Res; 1994; 22():155-66. PubMed ID: 7771330
    [No Abstract]   [Full Text] [Related]  

  • 16. Interactions among prostaglandin receptors.
    Ashby B
    Receptor; 1994; 4(1):31-42. PubMed ID: 8038705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
    Meja KK; Barnes PJ; Giembycz MA
    Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The history of the pharmacology and cloning of ionotropic glutamate receptors and the development of idiosyncratic nomenclature.
    Lodge D
    Neuropharmacology; 2009 Jan; 56(1):6-21. PubMed ID: 18765242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional pharmacology of human prostanoid EP2 and EP4 receptors.
    Wilson RJ; Rhodes SA; Wood RL; Shield VJ; Noel LS; Gray DW; Giles H
    Eur J Pharmacol; 2004 Oct; 501(1-3):49-58. PubMed ID: 15464062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus-classification, nomenclature and the International Committee on Nomenclature of Viruses.
    Wildy P; Ginsberg HS; Brandes J; Maurin J
    Prog Med Virol; 1967; 9():476-82. PubMed ID: 6066183
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.